The Ministry of Health has published EBOLA DRC - Evolution of the response to the Ebola outbreak in the provinces of North Kivu and Ituri to Friday, April 26, 2019. Not only do we have the most cases in a day since the outbreak began, but we have ten deaths—eight of them in the community—and a total of 900 since August 1. Excerpt from the Google translation:
EPIDEMIOLOGICAL SITUATION IN THE PROVINCES OF NORTH KIVU AND ITURI
Friday, April 26, 2019
The epidemiological situation of the Ebola Virus Disease dated April 25, 2019:
• Since the beginning of the epidemic, the cumulative number of cases is 1,396, of which 1,330 are confirmed and 66 are probable. In total, there were 900 deaths (834 confirmed and 66 probable) and 394 people healed.
• 260 suspected cases under investigation;
• 23 new confirmed cases, including 9 in Katwa, 4 in Mandima, 3 in Musienene, 2 in Butembo, 2 in Kalunguta, 1 in Vuhovi, 1 in Komanda and 1 in Mabalako;
• 10 new confirmed cases, including
º 8 community deaths, including 5 in Katwa, 1 in Musienene, 1 in Kalunguta and 1 in Mabalako;
• 2 deaths at Katwa CTE.
/! \ The data presented in this table are subject to change later, after extensive investigations and after redistribution of cases and deaths in their health areas.
News of the response
Vaccination
• Since the beginning of vaccination on 8 August 2018, 105,757 persons have been vaccinated , including 28,279 in Katwa, 23,004 in Beni, 12,826 in Butembo, 6,874 in Mabalako, 4,662 in Mandima, 3,180 in Kalunguta, 3,070 in Goma, 2,669 in Komanda, 2,569 in Oicha, 1,845 in Vuhovi, 1,819 in Masereka, 1,689 in Kyondo, 1,630 in Kayina, 1,487 in Bunia, 1,357 in Karisimbi, 1,233 in Lubero, 1,027 in Musienene, 1,025 in Biena, 772 in Mutwanga, 690 in Rutshuru, 557 in Rwampara (Ituri), 527 in Nyankunde, 496 in Mangurujipa, 420 in Mambasa, 355 in Tchomia, 342 in Kirotshe, 333 in Lolwa, 254 in Alimbongo, 250 in Mweso, 245 in Kibirizi, 161 in Nyiragongo, 97 in Watsa (Haut-Uélé) and 13 in Kisangani.
• The only vaccine to be used in this outbreak is the rVSV-ZEBOV vaccine, manufactured by the pharmaceutical group Merck, following approval by the Ethics Committee in its decision of 19 May 2018.
Recent Comments